News

First and Only Intrasaccular Aneurysm Treatment Device

Capital Investment in Terumo Yamaguchi D&D for Pre-filled Syringes

Coalition of Blood for Africa is the first of its kind in the continent

Japan’s First Patch Pump for Insulin Delivery

The Company Appoints New President and CEO

Terumo Announces a Major Release of Clinical Outcome Data from Over 37,000 Patients Enrolled in e-ULTIMASTER, the Largest Ever Percutaneous Coronary Intervention (PCI) Registry Reporting Contemporary Drug-eluting Stent Outcomes

Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO

To Mitigate Climate Change Risks by Science-based Approach

Product optimized to stop bleeding during aortic surgical procedures

First patient enrolled in the DISCO RADIAL study

The WEB™ is the first intrasaccular flow disruptor approved for the embolization of wide neck bifurcation aneurysms